Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis C treatment news

Show

From To
Optimism About HCV Treatment Comes With Caveats

Despite significant advances in treatment for individuals with HCV infection, several important issues prevail in this patient population.

Published
22 March 2017
From
Medscape
Drugs costing 8p a day could be hit by 'devastating' NHS rationing plan

At present, the NHS has 90 days to make drugs available to patients, once they have been given the green light by the National Institute of Health and Care Excellence (Nice). The new system will allow health officials an extra three years to introduce drugs, during which time they will try to negotiate cost reductions.

Published
16 March 2017
From
Telegraph
Malaysia: MOH to propose importing generic Hepatitis C meds

The Health Ministry will table a working paper to the Cabinet committee for approval to import of generic drugs to treat Hepatitis C.

Published
14 March 2017
From
Malay Mail Online
Glecaprevir/pibrentasvir for hepatitis C can be safely administered with common antiretrovirals

AbbVie's investigational glecaprevir/pibrentasvir treatment for hepatitis C is not expected to interact with or require dose adjustment when taken with commonly used antiretroviral regimens, offering a new option

Published
10 March 2017
By
Liz Highleyman
DAA therapy cures most people with HIV/HCV co-infection with decompensated cirrhosis or liver transplants

People with HIV/hepatitis C virus (HCV) co-infection with liver cirrhosis or liver failure, and those who received liver transplants, saw high rates of sustained virological response using

Published
08 March 2017
By
Liz Highleyman
Hepatitis C patients and nurses highlight impact of the virus in new reports

The reports, titled Patient Perspectives and Nurses' Perspectives, were written after a series of interviews with patients and an online survey with nurses, and lay bare not only the reality of how treatment rationing affects patients and nurses, but also the stigma, fear and isolation still felt by many people living with hepatitis C.

Published
07 March 2017
From
Hepatitis C Trust
'I bought hepatitis C cure from Bangladesh'

Zoe Sharam bought a hepatitis C cure, deemed too expensive for her by the NHS, online from Bangladesh. She speaks to the BBC's Victoria Derbyshire programme.

Published
02 March 2017
From
BBC Health
Hepatitis C drugs re-energize global fight over patents

The liver disease hepatitis C is the new battleground for lawsuits intended to slash the cost of life-saving medicines. In February alone, five suits were filed in India and Argentina claiming that the latest class of antiviral drugs does not warrant the 20-year patent monopoly that manufacturers have sought in those countries.

Published
01 March 2017
From
Nature
Ukraine signs amicable agreement with Gilead on hepatitis C drug

Ukraine has signed an amicable agreement with U.S. Gilead Sciences, Inc. biopharmaceutical company on the Sovaldi medicine used to treat chronic hepatitis C infection in adults, acting Ukrainian Health Minister Ulana Suprun said at a press conference on Wednesday. The whole course of hepatitis C treatment with the use of Sovaldi in Ukraine will cost about $750.

Published
27 February 2017
From
Interfax Ukraine
Are people with HIV and HCV co-infection who are cured of hepatitis C with DAAs at increased risk for liver cancer?

People with HIV and hepatitis C virus (HCV) co-infection who are successfully treated for hepatitis C using interferon-free direct-acting antiviral (DAA) therapy do not appear to have

Published
27 February 2017
By
Liz Highleyman
← First12345...88Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.